Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Cyclically Adjusted Revenue per Share: $5.68 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JCARE Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
80 GF Score
Price $8.00
GF Value $9.20
! 3 Warning Signs
View Full Analysis

What is Joincare Pharmaceutical Group Industry Co Cyclically Adjusted Revenue per Share?

Joincare Pharmaceutical Group Industry Co XSWX:JCARE 80 Cyclically Adjusted Revenue per Share is $5.68 as of Mar. 2026. GuruFocus rates XSWX:JCARE with a GF Score™ of 80/100 and a GF Value™ of $9.20. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Joincare Pharmaceutical Group Industry Co's adjusted revenue per share for the three months ended in Mar. 2026 was $2.993. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $5.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Joincare Pharmaceutical Group Industry Co's average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Joincare Pharmaceutical Group Industry Co was 18.10% per year. The lowest was 5.00% per year. And the median was 14.00% per year.

As of today (2026-08-13), Joincare Pharmaceutical Group Industry Co's current stock price is $8.00. Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $5.68. Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted PS Ratio of today is 1.41.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Joincare Pharmaceutical Group Industry Co was 3.78. The lowest was 1.17. And the median was 1.88.


Joincare Pharmaceutical Group Industry Co  (XSWX:JCARE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8.00/5.68
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Joincare Pharmaceutical Group Industry Co was 3.78. The lowest was 1.17. And the median was 1.88.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Joincare Pharmaceutical Group Industry Co Cyclically Adjusted Revenue per Share Related Terms


Joincare Pharmaceutical Group Industry Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joincare Pharmaceutical Group Industry Co Cyclically Adjusted Revenue per Share Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 8.42 4.64 5.36 5.45

Joincare Pharmaceutical Group Industry Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.27 5.58 4.99 5.45 5.68

XSWX:JCARE vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted PS Ratio falls into.


XSWX:JCARE
80GF Score
Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Joincare Pharmaceutical Group Industry Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Joincare Pharmaceutical Group Industry Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.993/116.3033*116.3033
=2.993

Current CPI (Mar. 2026) = 116.3033.

Joincare Pharmaceutical Group Industry Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.197 101.400 2.520
201609 2.125 102.400 2.414
201612 1.966 102.600 2.229
201703 2.313 103.200 2.607
201706 2.186 103.100 2.466
201709 2.430 104.100 2.715
201712 3.618 104.500 4.027
201803 3.036 105.300 3.353
201806 2.701 104.900 2.995
201809 2.693 106.600 2.938
201812 2.035 106.500 2.222
201903 2.570 107.700 2.775
201906 2.199 107.700 2.375
201909 2.182 109.800 2.311
201912 1.965 111.200 2.055
202003 2.333 112.300 2.416
202006 2.377 110.400 2.504
202009 2.756 111.700 2.870
202012 2.637 111.500 2.751
202103 3.248 112.662 3.353
202106 2.926 111.769 3.045
202109 3.236 112.215 3.354
202112 3.332 113.108 3.426
202203 3.841 114.335 3.907
202206 3.111 114.558 3.158
202209 3.382 115.339 3.410
202212 3.074 115.116 3.106
202303 3.428 115.116 3.463
202306 3.047 114.558 3.093
202309 2.829 115.339 2.853
202312 2.989 114.781 3.029
202403 3.289 115.227 3.320
202406 2.879 114.781 2.917
202409 2.649 115.785 2.661
202412 2.773 114.893 2.807
202503 2.977 115.116 3.008
202506 3.021 114.907 3.058
202509 2.784 115.471 2.804
202512 2.850 115.832 2.862
202603 2.993 116.303 2.993

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $5.68 mean?
Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) has a Cyclically Adjusted Revenue per Share of $5.68 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors.
Is Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted Revenue per Share too high?
Joincare Pharmaceutical Group Industry Co's current Cyclically Adjusted Revenue per Share is $5.68. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted Revenue per Share compare to ZTS?
Joincare Pharmaceutical Group Industry Co's Cyclically Adjusted Revenue per Share of $5.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. Joincare Pharmaceutical Group Industry Co's current Cyclically Adjusted Revenue per Share is $5.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) has a current Cyclically Adjusted Revenue per Share of $5.68. The stock's GF Value™ is $9.20, compared to a current price of $8.00 — trading 13% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $5.68. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (XSWX:JCARE), the current Cyclically Adjusted Revenue per Share is $5.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Overvalued in 2026?

Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued. The current stock price of $8.00 is trading 13% below its estimated GF Value™ of $9.20.

Key valuation signals for XSWX:JCARE:

  • Cyclically Adjusted Revenue per Share: $5.68
  • GF Value™: $9.20 vs. price of $8.00 (13% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the XSWX:JCARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Joincare Pharmaceutical Group Industry Co Business Description

Other Exchanges 600380:China
Address No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score

Get the complete analysis for XSWX:JCARE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$9.20
GF Value